RXL250117C58000
- 0.00
- 0.000.00%
Proshares Trust Pshs Ult Hlthcre Newsroom
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
AbbVie Announced Q4 2024 Earnings To Include $1.6B Acquired IPR&D Costs, Impacting EPS By $0.88; Final Results Pending; Q4 Adj EPS $2.06-$2.10; FY24 Adj EPS Guidance $10.02-$10.06
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Stock Of The Day: Will Johnson & Johnson Take The Market Lower?
Merck to Buy Vaccine Plant From WuXi Biologics: Report
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Citi's Recommended List of Large-cap Stocks: GOOGL, STZ, DAL, and More
BofA's Growth 10 Screen as January 2025 Trade Revs up
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
WUXI BIO has once again divested overseas Assets! Merck takes over WUXI BIO's Ireland vaccine factory for 0.5 billion USD | Quick read announcement.
① WUXI BIO announced today that it will sell the Ireland vaccine factory to Merck for 0.5 billion USD; ② this vaccine factory was originally built to undertake Merck's vaccine contract manufacturing business; ③ not long ago, WUXI APPTEC also divested its WuXi ATU business in the USA and United Kingdom.
Truist Securities Maintains Buy on UnitedHealth Group, Lowers Price Target to $610
UnitedHealth Group Analyst Ratings
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?
U.S. Healthcare Execs Turn More Bullish for 2025: Deloitte
Novo Nordisk Seeks to Block Compounded Victoza
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Catalyst Watch: CES, M&A Votes and the Supreme Court Tackles the TikTok Case
Smart Money Is Betting Big In LLY Options